We are live on ! Find out more
ARCKW

Arbor Rapha Capital Bioholdings Corp. I Warrants
ARCKW

Delisted

ARCKW was delisted on the 10th of January, 2023.

Back to rankings

1 hedge funds and large institutions have $0 invested in Arbor Rapha Capital Bioholdings Corp. I Warrants in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 43 → 1 (-42)

100% less capital invested

Capital invested by funds: $2.33M → $0 (-$2.33M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 42

Holders
1
Holders Change
-42
Holders Change %
-97.67%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
42
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
Radcliffe Capital Management
Pennsylvania
-$1.08M
2
LP
LMR Partners
United Kingdom
-$723K
3
AFM
Anson Funds Management
Texas
-$362K
4
SCM
Saba Capital Management
New York
-$16.3K
5
HIM
HGC Investment Management
Ontario, Canada
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
– -$16.3K -377,574 Closed
QGA
2
Q Global Advisors
Texas
– -$8K -200,810 Closed
HIM
3
HGC Investment Management
Ontario, Canada
– -$8K -200,000 Closed
SCM
4
Shaolin Capital Management
Florida
– -$8K -189,221 Closed
MI
5
MMCAP International
Cayman Islands
– -$7.33K -183,332 Closed
CSS
6
Cubist Systematic Strategies
Connecticut
– -$7.15K -178,794 Closed
LA
7
Linden Advisors
New York
– -$7.67K -177,932 Closed
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
– -$6.75K -166,666 Closed
PMAM
9
Picton Mahoney Asset Management
Ontario, Canada
– -$6K -166,666 Closed
PAMP
10
Polar Asset Management Partners
Ontario, Canada
– -$5.53K -138,350 Closed
DKCM
11
Davidson Kempner Capital Management
New York
– -$5K -116,667 Closed
AC
12
Aristeia Capital
Connecticut
– -$5.03K -116,666 Closed
ACM
13
Atalaya Capital Management
New York
– -$4.67K -116,666 Closed
Calamos Advisors
14
Calamos Advisors
Illinois
– -$4.72K -116,666 Closed
SC
15
Sculptor Capital
New York
– -$5.03K -116,664 Closed
AA
16
AQR Arbitrage
Connecticut
– -$4.69K -115,848 Closed
CCA
17
Castle Creek Arbitrage
Colorado
– -$4.57K -114,172 Closed
CCM
18
Context Capital Management
California
– -$4K -103,096 Closed
RCM
19
Radcliffe Capital Management
Pennsylvania
– -$1.08M -99,999 Closed
CF
20
Cantor Fitzgerald
New York
– -$4K -96,166 Closed
TCM
21
Tenor Capital Management
New York
– -$3.33K -83,333 Closed
PC
22
Periscope Capital
Ontario, Canada
– -$3.24K -80,900 Closed
Balyasny Asset Management
23
Balyasny Asset Management
Illinois
– -$2.7K -66,666 Closed
LP
24
LMR Partners
United Kingdom
– -$723K -66,666 Closed
Goldman Sachs
25
Goldman Sachs
New York
– -$2.62K -65,585 Closed
1
2

ARCKW Hedge Fund Activity: Q1 2023 in Review

1 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Warrants (ARCKW) for Q1 2023, worth a combined $0 — down 100% from $2.33M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of ARCKW and 0 opened new positions — a net loss of 42 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $1.08M sold.

  • 1 institutional investor held Arbor Rapha Capital Bioholdings Corp. I Warrants (ARCKW) as of Q1 2023, down from 43 in Q4 2022.
  • Funds reported $0 of Arbor Rapha Capital Bioholdings Corp. I Warrants stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Arbor Rapha Capital Bioholdings Corp. I Warrants positions in Q1 2023 and 42 closed out, a net change of -42 holders.
  • The largest Arbor Rapha Capital Bioholdings Corp. I Warrants seller in Q1 2023 was Radcliffe Capital Management, an estimated $1.08M sold.

Based on aggregated 13F filings for Q1 2023.